Innovative medicines to protect vision.
Revising how medicines are developed and commercialized.
reVision is developing a treatment for Stargardt disease.
On January 27, we observe International Holocaust Remembrance Day. Explore further details about this annual day of commemoration on our LinkedIn page. #HolocaustRemembranceDay#WeRemember
https://t.co/fLM2ll6wUw
On Martin Luther King Jr. Day, let us reflect on the impact Dr. King made through his commitment to the advancement of our nation. #MLKDay#MLK2024#Service#DEI
#GlaucomaAwarenessMonth is observed in January, highlighting #glaucoma as a major contributor to irreversible blindness. Explore more details on our LinkedIn page. #EyeHealth
https://t.co/fLM2ll6wUw
Did you know? Dr. Karl Bruno Stargardt, best known as the first doctor to describe #StargardtDisease, was born on December 4, 1875. Learn more at our LinkedIn page. #Stargardt
https://t.co/fLM2ll74K4
Today is the International Day of Persons with Disabilities. Learn more about the UN’s goals with the observance on our LinkedIn page. #DEI
https://t.co/fLM2ll6wUw
Today is #NationalNativeAmericanHeritageDay, honoring Native Americans and celebrating the vibrant cultures, traditions, and heritages. Learn more about American Indian eye health in the image below. #DEI
Thank you to all the veterans who have dedicated their lives to protecting our country. We are grateful today and always for the service, sacrifice, and bravery of our veterans, current military members, and their families. #VeteransDay
Don’t let your Halloween become a real-life horror story! Learn more about eye safety and health for #HalloweenEyeSafetyMonth at our LinkedIn page! https://t.co/fLM2ll74K4
#WorldSightDay is an international day of awareness about the importance of eye health and encourages everyone to protect and maintain eye health. Eye health is central to education, employment, poverty, and quality of life. #LoveYourEyes#EyeHealth#reVision
Learn about #IndigenousPeoplesDay and findings from JAMA Ophthalmology’s 2021 study about ophthalmic conditions in the North American Native community at our LinkedIn page. #DEI
https://t.co/fLM2ll6wUw
#reVision participated in the @StargardtsC Community Zoom, where Dr. Paul Fehlner provided an overview of our lead program, REV-0100, for #StargardtDisease. If you missed the presentation, you can watch it on our website at the link below. #RareDisease
https://t.co/G6wudkO4KY